跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 536,797 条关于
“Maintenance of Wakefulness Test”
全部
536,797
临床试验
488,087
药物
4,594
机构
3,336
资讯
40,780
去年
Centessa Pharmaceuticals Appoints Stephen Kanes as Chief Medical Officer to Advance Orexin Agonist Program
上个月
Orexin Receptor Agonists Herald a New Era for Narcolepsy Type 1 Treatment
去年
LUMRYZ Maintains Market Exclusivity as Court Upholds FDA Approval in Narcolepsy Treatment
去年
iNGENu CRO Launches Pioneering Clinical Trials for Idiopathic Hypersomnia and Narcolepsy
去年
Avadel's LUMRYZ Maintains Market Exclusivity as Court Upholds FDA Approval
2年前
Takeda Advances TAK-861 to Phase III for Narcolepsy Type 1 Following Positive Phase IIb Results
2年前
Centessa's ORX750 Advances to Phase 2 for Narcolepsy and Idiopathic Hypersomnia After Promising Phase 1 Results
9个月前
Centessa Pharmaceuticals Advances Orexin Agonist Pipeline with Leadership Transition and Promising Clinical Data
去年
FDA Approves Once-Nightly Sodium Oxybate (Lumryz) for Pediatric Narcolepsy
11个月前
Avadel and Jazz Pharmaceuticals Settle $90 Million Narcolepsy Drug Dispute Over Lumryz
第 1 页，共 4078 页
上一页
下一页
